Overview

Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to study if two different tablet formulations of doxycycline are bioequivalent to each other.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Doxycycline